PL378713A1 - Kompozycje przeciwpierwotniakowe, zawierające diklazuryl - Google Patents
Kompozycje przeciwpierwotniakowe, zawierające diklazurylInfo
- Publication number
- PL378713A1 PL378713A1 PL378713A PL37871304A PL378713A1 PL 378713 A1 PL378713 A1 PL 378713A1 PL 378713 A PL378713 A PL 378713A PL 37871304 A PL37871304 A PL 37871304A PL 378713 A1 PL378713 A1 PL 378713A1
- Authority
- PL
- Poland
- Prior art keywords
- protozoal
- compositions
- diclazuril
- protozoal compositions
- prepraring
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000003904 antiprotozoal agent Substances 0.000 title abstract 3
- 230000000842 anti-protozoal effect Effects 0.000 title abstract 2
- ZSZFUDFOPOMEET-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1C(C#N)C1=C(Cl)C=C(N2C(NC(=O)C=N2)=O)C=C1Cl ZSZFUDFOPOMEET-UHFFFAOYSA-N 0.000 title 1
- 229960000248 diclazuril Drugs 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010037075 Protozoal infections Diseases 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP0300398 | 2003-01-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL378713A1 true PL378713A1 (pl) | 2006-05-15 |
Family
ID=32695546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL378713A PL378713A1 (pl) | 2003-01-16 | 2004-01-09 | Kompozycje przeciwpierwotniakowe, zawierające diklazuryl |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060240049A1 (pl) |
| KR (1) | KR20050091062A (pl) |
| AT (1) | ATE376422T1 (pl) |
| BR (1) | BRPI0406795A (pl) |
| CA (1) | CA2512176A1 (pl) |
| DE (1) | DE602004009664D1 (pl) |
| MX (1) | MXPA05007601A (pl) |
| MY (1) | MY141593A (pl) |
| PL (1) | PL378713A1 (pl) |
| TW (1) | TW200507873A (pl) |
| WO (1) | WO2004062673A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
| KR100683193B1 (ko) | 2005-07-30 | 2007-02-15 | 주식회사유한양행 | 디클라주릴-함유 약제학적 조성물의 제조방법 |
| DE102006038292A1 (de) * | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen |
| CN102743334A (zh) * | 2012-07-30 | 2012-10-24 | 郑州后羿制药有限公司 | 一种妥曲珠利注射剂及其制备方法 |
| CN102973496B (zh) * | 2012-11-22 | 2014-12-17 | 青岛绿曼生物工程有限公司 | 一种治疗家禽球虫病的地克珠利口服液的制备方法 |
| CN105213311A (zh) * | 2015-11-05 | 2016-01-06 | 南阳农业职业学院 | 地克珠利亚微乳的制备方法 |
| ES2897988T3 (es) * | 2016-07-13 | 2022-03-03 | Univ Paris | Derivados de meclozina para la utilización en la prevención y/o el tratamiento de trastornos asociados a la inflamación inducida por P. acnes |
| US10702475B2 (en) | 2017-09-05 | 2020-07-07 | Richard Rigg | Liposome containing compositions and their use in personal care and food products |
| US12564571B2 (en) | 2018-02-20 | 2026-03-03 | Going Big Time, Inc. | Compositions and methods for the treatment of equine protozoal myeloencephalitis |
| EP3578181A1 (en) | 2018-06-05 | 2019-12-11 | Bayer Animal Health GmbH | Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies |
| CN108904514B (zh) * | 2018-07-26 | 2021-03-26 | 日照市牧邦畜牧科技有限公司 | 一种稳定长效复方地克珠利溶液 |
| WO2025171002A1 (en) * | 2024-02-05 | 2025-08-14 | Elanco Us Inc. | Multi-layered granule therapeutics |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3703103A1 (de) * | 1987-02-03 | 1988-08-11 | Bayer Ag | Mittel gegen fischparsiten |
| US5883095A (en) * | 1997-08-07 | 1999-03-16 | University Of Kentucky Research Foundation | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
| WO1998043644A1 (en) * | 1997-03-31 | 1998-10-08 | David Granstrom | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
| US6194408B1 (en) * | 1998-12-22 | 2001-02-27 | Bayer Corporation | Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma |
-
2004
- 2004-01-09 PL PL378713A patent/PL378713A1/pl not_active Application Discontinuation
- 2004-01-09 CA CA002512176A patent/CA2512176A1/en not_active Abandoned
- 2004-01-09 MX MXPA05007601A patent/MXPA05007601A/es not_active Application Discontinuation
- 2004-01-09 KR KR1020057012657A patent/KR20050091062A/ko not_active Withdrawn
- 2004-01-09 US US10/542,162 patent/US20060240049A1/en not_active Abandoned
- 2004-01-09 BR BR0406795-9A patent/BRPI0406795A/pt not_active IP Right Cessation
- 2004-01-09 AT AT04701010T patent/ATE376422T1/de not_active IP Right Cessation
- 2004-01-09 WO PCT/EP2004/000147 patent/WO2004062673A1/en not_active Ceased
- 2004-01-09 DE DE602004009664T patent/DE602004009664D1/de not_active Expired - Lifetime
- 2004-01-14 MY MYPI20040100A patent/MY141593A/en unknown
- 2004-01-15 TW TW093100959A patent/TW200507873A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050091062A (ko) | 2005-09-14 |
| WO2004062673A1 (en) | 2004-07-29 |
| TW200507873A (en) | 2005-03-01 |
| MXPA05007601A (es) | 2005-09-30 |
| US20060240049A1 (en) | 2006-10-26 |
| BRPI0406795A (pt) | 2006-01-17 |
| ATE376422T1 (de) | 2007-11-15 |
| MY141593A (en) | 2010-05-14 |
| DE602004009664D1 (de) | 2007-12-06 |
| CA2512176A1 (en) | 2004-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9801420A0 (en) | Novel macrolides. | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| SG155967A1 (en) | Hcv ns3-ns4a protease inhibition | |
| MXPA05008126A (es) | Inhibidores de girasa y uso de los mismos. | |
| EA200200778A1 (ru) | СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С В ОРГАНИЗМЕ ХОЗЯИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ПРОТИВ ФЛАВИВИРУСА, СОЕДИНЕНИЕ ФОРМУЛЫ Ib - АКТИВНЫЙ АГЕНТ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С ИЛИ ФЛАВИВИРУСА (ВАРИАНТЫ) | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| MY148123A (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| TW200612898A (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same | |
| ATE391708T1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
| WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| MXPA04012965A (es) | Inhibidores virales. | |
| MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
| MXPA04003932A (es) | Inhibidores de la hidroxipirimidinona carboxamida n-sustituida de la integrasa del virus de inmunodeficiencia humana. | |
| MY148690A (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| PL374191A1 (pl) | Pochodne kwasu 2-ureido-6-heteroarylo-3H-benzoimidazolo-4-karboksylowego i pokrewne związki jako inhibitory gyrazy i/lub topoizomerazy IV do leczeniazakażeń bakteryjnych | |
| MXPA05007601A (es) | Composiciones anti-protozoos que comprenden diclazuril. | |
| PL1789419T3 (pl) | Inhibitory gyrazy i ich zastosowanie | |
| TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| PT828728E (pt) | Di-hidrobenzofuranos de fenilo | |
| PL1697371T3 (pl) | Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego | |
| AP2001002142A0 (en) | 13-membered azalides and their use as antibiotic agents. | |
| MX2007007598A (es) | Macrolidos. | |
| PT1581235E (pt) | Utilização de espongosina (2-metoxiadenoseína) para o tratamento de dor, em particular hiperalgesia | |
| MXPA03007885A (es) | Norbuprenorfina n-but-3-enilo y metodos de uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |